OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Research Progress on Catalpol as Treatment for Atherosclerosis
Lei He, Rusheng Zhao, Youheng Wang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 24

Showing 24 citing articles:

Structure Optimization of Natural Product Catalpol to Obtain Novel and Potent Analogs against Heart Failure
Hanfang Liu, Xiaobo Guo, Jin Yang, et al.
Journal of Medicinal Chemistry (2025)
Closed Access | Times Cited: 3

Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes
Ilaria Piccialli, Valentina Tedeschi, Lucia Caputo, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 40

The Role of Sirtuin 1 in Ageing and Neurodegenerative Disease: A Molecular Perspective
Riya Thapa, Ehssan Moglad, Muhammad Afzal, et al.
Ageing Research Reviews (2024) Vol. 102, pp. 102545-102545
Closed Access | Times Cited: 10

Plant-derived natural medicines for the management of osteoporosis: A comprehensive review of clinical trials
Seyedeh Mahnaz Karimi, Mohammad Bayat, Roja Rahimi
Journal of Traditional and Complementary Medicine (2023) Vol. 14, Iss. 1, pp. 1-18
Open Access | Times Cited: 19

Iridoids modulate inflammation in diabetic kidney disease: A review
Tongyi Zhou, Na Tian, Liu Li, et al.
Journal of Integrative Medicine (2024) Vol. 22, Iss. 3, pp. 210-222
Closed Access | Times Cited: 6

Exploration of the Dynamic Variations of the Characteristic Constituents and the Degradation Products of Catalpol during the Process of Radix Rehmanniae
Jingjing Yang, Lihua Zhang, Meng-Yue Zhang, et al.
Molecules (2024) Vol. 29, Iss. 3, pp. 705-705
Open Access | Times Cited: 5

Protective Effect and Mechanism of Plant-Based Monoterpenoids in Non-alcoholic Fatty Liver Diseases
Wenji Zhang, Hui Lin, Wenli Cheng, et al.
Journal of Agricultural and Food Chemistry (2022) Vol. 70, Iss. 16, pp. 4839-4859
Closed Access | Times Cited: 20

Multifaceted therapeutic potentials of catalpol, an iridoid glycoside: an updated comprehensive review
Mennat-Allah M. Hassan, Mohamed I. Fahmy, Hany N. Azzam, et al.
Inflammopharmacology (2025)
Open Access

Anti‐inflammatory effect and mechanism of catalpol in various inflammatory diseases
Jinyao Liu, Shuang Liu, Mingyue Yu, et al.
Drug Development Research (2023) Vol. 84, Iss. 7, pp. 1376-1394
Closed Access | Times Cited: 8

Catalpol Alleviates Ischemic Stroke Through Promoting Angiogenesis and Facilitating Proliferation and Differentiation of Neural Stem Cells via the VEGF-A/KDR Pathway
Si Sun, Yitong Xu, Ningxi Yu, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 11, pp. 6227-6247
Closed Access | Times Cited: 8

The Mechanism of Catalpol to Improve Oxidative Damage of Dermal Fibroblasts Based on Nrf2/HO-1 Signaling Pathway
Xiaona Lang, Li‐Yan Xu, Lü Li, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 2287-2297
Open Access | Times Cited: 2

Catalpol ameliorates CFA-induced inflammatory pain by targeting spinal cord and peripheral inflammation
Baoxia Zhao, Jie Fu, Huadong Ni, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 11

A narrative review of plant and herbal medicines for delaying diabetic atherosclerosis: an update and future perspectives
Zi-Chao Wang, Jeremiah Ong’achwa Machuki, Mengzhen Li, et al.
Reviews in Cardiovascular Medicine (2021) Vol. 22, Iss. 4
Open Access | Times Cited: 11

Catalpol inhibits HHcy-induced EndMT in endothelial cells by modulating ROS/NF-κB signaling
Chengyan Wu, Yuanhao Li, Shuangshuang Liu, et al.
BMC Cardiovascular Disorders (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1

Catalpol improved energy metabolism and inflammation through the SIRT5-mediated signaling pathway to ameliorate myocardial injury
Zihan Zheng, YiZhen Liu, Danli Chen, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1

Integrin beta 3-overexpressing mesenchymal stromal cells display enhanced homing and can reduce atherosclerotic plaque
Haijuan Hu, Xue-Ru Xiao, Tong Li, et al.
World Journal of Stem Cells (2023) Vol. 15, Iss. 9, pp. 931-946
Open Access | Times Cited: 3

Catalpol Inhibits Autophagy to Ameliorate Doxorubicin-Induced Cardiotoxicity via the AKT-mTOR Pathway
Bo Liu, Han Xie, Xiongbing Du, et al.
International Heart Journal (2023) Vol. 64, Iss. 5, pp. 910-917
Open Access | Times Cited: 3

Recent Advances in Traditional Chinese Medicine for Treatment of Podocyte Injury
Tianwen Yao, Wenxiang Su, Shisheng Han, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 5

Paraoxonase 2 C311S single nucleotide polymorphism is associated with type C lesions in coronary atherosclerosis
Elżbieta Paszek, Jacek Godlewski, Paweł Wołkow, et al.
Clinical Biochemistry (2022) Vol. 105-106, pp. 64-69
Closed Access | Times Cited: 3

Catalpol inhibits HHcy-induced EndMT in endothelial cells by modulating ROS/NF-κB signaling
Chengyan Wu, Libo Wang, Xuehui Wang
Research Square (Research Square) (2023)
Open Access

Multifaceted Effects of Catalpol on Promotion of Perforator Flaps Survival in Rats
Yihan Wang, Dingchao Zhu, Jiajing Xu, et al.
SSRN Electronic Journal (2021)
Closed Access

Page 1

Scroll to top